Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.160
+0.570 (15.88%)
At close: Feb 27, 2026, 4:00 PM EST
4.140
-0.020 (-0.48%)
After-hours: Feb 27, 2026, 7:57 PM EST
Opus Genetics Employees
Opus Genetics had 18 employees as of December 31, 2024. The number of employees increased by 4 or 28.57% compared to the previous year.
Employees
18
Change (1Y)
4
Growth (1Y)
28.57%
Revenue / Employee
$812,944
Profits / Employee
-$3,789,056
Market Cap
286.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 18 | 4 | 28.57% |
| Dec 31, 2023 | 14 | 5 | 55.56% |
| Dec 31, 2022 | 9 | 1 | 12.50% |
| Dec 31, 2021 | 8 | 3 | 60.00% |
| Dec 31, 2020 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| Puma Biotechnology | 172 |
| AC Immune | 172 |
| X4 Pharmaceuticals | 143 |
| Abeona Therapeutics | 136 |
| Adlai Nortye | 123 |
| Enlivex | 71 |
| ALX Oncology Holdings | 44 |
IRD News
- 20 hours ago - Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting - GlobeNewsWire
- 2 days ago - Opus Genetics Announces FDA Acceptance of Supplemental New Drug Application for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia - GlobeNewsWire
- 5 days ago - Opus Genetics: Asymmetric Upside With LCA5 And BEST1 - Seeking Alpha
- 14 days ago - Opus Genetics Announces $25 Million Private Placement - GlobeNewsWire
- 25 days ago - Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026 - GlobeNewsWire
- 4 weeks ago - Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa - GlobeNewsWire
- 6 weeks ago - Opus Genetics, Inc. (IRD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts - GlobeNewsWire